Advances in Immunotherapy of Chronic Myeloid Leukemia CML

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|7|768-774

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.7, 2013-09, pp. : 768-774

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 735-748

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-01 ,pp. : 775-778

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

Blackwell Publishing

Access to resources Recommend Favorite

Immunotherapy of Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for chronic myeloid leukemia

By Tanaka Maria Florencia   Kantarjian Hagop   Cortes Jorge   Ohanian Maro   Jabbour Elias  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 815-828

Informa Healthcare

Access to resources Recommend Favorite